Was it not a buy back at a discounted rate. Anyhow imo if the stock was trading in this market it would be down. Interesting they are looking at more opportunities.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025